Vibratess’ Recent Publications
I. Publications listed in previous sections
3-1. Globus T, Ferrance J, Moskaluk C, Gelmont B, Bykhovski A (2018) "Sub-Terahertz Spectroscopic Signatures from micro-RNA Molecules in Fluid Samples for Ovarian Cancer Analysis". Case Rep Lit Rev 2(2): 100012, https://www.onjourn.com/case-reports-and-literature-review.php
3-2.: T. Globus, I. Sizov, J. Ferrance, A. Jazaeri, J. Bryant, A. Moyer, B. Gelmont, M. Kester and A. Bykhovski, "Sub-terahertz vibrational spectroscopy for microRNA based diagnostic of ovarian cancer". Converg. Sci. Phys. Oncol. 2 (2016) http://dx.doi.org/10.1088/2057-1739/2/4/045001, )
3-3. T. Globus, C.Moskaluk, P. Pramoonjago, B. Gelmont, A. Moyer, A. Bykhovski, J. Ferrance, "Sub-Terahertz Vibrational Spectroscopy of Ovarian Cancer and Normal Control Tissue for Molecular Diagnostic Technology." submitted for publication to Cancer Biomarkers Journal. Tracking number 18-2120).
5-1. T. Globus, I. Sizov and B. Gelmont, Sub-THz specific relaxation times of hydrogen bond oscillations in E.coli thioredoxin. Molecular dynamics and statistical analysis. The Royal Society of Chemistry 2014, Faraday Discuss. 2014, 171, 1–15 | 3. DOI: 10.1039/c4fd00029c..
5-2 or 6-3. Globus T, Gelmont T. and Sizov I. ,Overview of THz spectral characterization for biological identification. Chapter 10, p. 281-312, In: Biological Identification, 1st Edition. DNA Amplification and Sequencing, Optical Sensing, Lab-On-Chip and Portable Systems. Ed: Schaudies P. Woodhead Publishing, UK, ISBN :9780857095015, 470 p., May 2014; .
II. Proposals submitted by Vibratess, LLC to the NIH/NCI.
1. Terahertz Spectroscopic Signatures from Ovarian cancer and related micro-rnas: experiment and computational prediction, 1R21CA191499-01, Febr 15_2014 2014, SBIR
2. Sub-Terahertz Spectroscopy Technology and Instrumentation for Early Cancer Detection, Diagnosis and Prognoses,
1 R43 CA193089-01 (MPI); SBIR-IMAT, PAR-13-327; May 29 2014, SBIR
3. THz Resonance Spectroscopy of HPV-Related Molecular Components for Cervical Cancer Early Detection & Prognosis, Sub-contract with UVA, 1 R01 CA195591-01, July-10-2014
4. Cell-Free Nucleic Acid-Based Assay Development for Cancer Diagnosis. Contract PHS 2015-1, Topic NCI 337, Nov 02, 2014
5. Sub-Terahertz Spectroscopy Instrumentation for Early Cancer Detection. 1 R43 CA 214342-01, June 04-2016
6. Development of Sub-Terahertz Spectroscopy and Instrumentation as Novel Optical Biomedical Technology for Early Cancers Detection, Diagnosis and Prognoses. PAR 14-088, Direct Phase II , 424 R&R and PHS Specific, January -5-2017
7.Cloud Based Software for Diagnostic Results from sub-THz Spectroscopic Measurements 1 R44 EB025100-01, PAR-15-288, 1-5- 2017, Direct Phase II SBIR Grants to Support Extended Development, Hardening, and Dissemination of Technologies in Biomedical Computing, Informatics, and Big Data Science (R44, January -5-2017
8. "Development of sub-THz Spectroscopy as a Tool for Companion Non-invasive Cancer Molecular Diagnostics Based on micro-RNA Profile", PA-18-574,PHS 2018-02, Omnibus Solicitation, Apri-4-2018
9.